• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Increased risk for breast cancer after childbirth may last more than 20 years

byCaitlyn HuiandDeepti Shroff Karhade
December 12, 2018
in Chronic Disease, Obstetrics, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The authors of the study concluded that parous women may have an elevated breast cancer risk for over 20 years following delivery.

2. The increased risk for breast cancer in parous women compared to nulliparous women was greatest at 5 years postpartum.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Breast cancer is an increasingly common malignancy found in our population. One widely recognized protective factor for breast cancer is childbirth, where women who have children at an older age or who are nulliparous are thought to have a higher risk of developing breast cancer later in life. While parity has been shown to be protective later in life, the authors of this study aimed to evaluate whether women had increased protection from breast cancer shortly after delivery. Pooled analysis showed that breast cancer risk was increased in parous women compared to nulliparous women for over 20 years with a peak risk at 5 years postpartum. Strengths of the study included the large number of cases in the pooled analysis of prospective cohorts.  One of the main limitations in this study was the identification of timing of breast cancer diagnosis. The authors acknowledged that breast cancer diagnoses during pregnancy were not always distinguishable from early postpartum diagnoses.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Pregnancy-related Characteristics and Breast Cancer Risk

In-Depth [prospective cohort]: The authors of this study conducted a pooled analysis of individual-level data from 15 prospective cohorts which were a part of the Premenopausal Breast Cancer Collaborative Group. The authors aimed to assess the risk of breast cancer related to recent childbirth. Participants were restricted to women younger than 55 years who did not have breast cancer prior to commencement of the study. The authors calculated hazard ratios comparing parous versus nulliparous women, looking at a total of 9.6 million person-years of follow-up. During this time frame, a total of 18 826 incident cases of breast cancer were diagnosed. When comparing parous to nulliparous women, parous women had a HR for breast cancer associated with time since recent birth that was highest after 4.6 years postpartum (HR, 1.80 [95% CI, 1.63 to 1.99]). The HR decreased to 0.77 34.5 years after birth (CI, 0.67 to 0.88) with a change to decreased risk occurring at 23.6 (95% CI, 21.9 to 25.0) years after childbirth primarily due to a change in the incidence of estrogen receptor-positive breast cancer.

RELATED REPORTS

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast CancerchildbirthER-positiveestrogen receptorpregnancy
Previous Post

2 Minute Medicine Rewind December 11, 2018

Next Post

The COAPT: Transcatheter mitral valve repair lowers mortality in patients with heart failure and mitral regurgitation

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Chronic Disease

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

March 12, 2023
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Gastroenterology

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

March 8, 2023
#StudyGraphics: Adjuvant abemaciclib improves survival in patients  with hormone receptor-positive early breast cancer
StudyGraphics

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

March 8, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Erythritol and Heart Problems, Maternal Health Trends, the Next Big Thing in Diabetes, and Declining Levels of Sea Ice

March 7, 2023
Next Post
Patient Basics: Heart Murmur

The COAPT: Transcatheter mitral valve repair lowers mortality in patients with heart failure and mitral regurgitation

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Radical prostatectomy significantly improves survival in localized prostate cancer: the SPCG-4 trial

Modified embryonic stem cells may prolong survival of surgical grafts

Quick Take: Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Similar perinatal outcomes observed amongst conception via natural and assisted reproductive means
  • Combination doxycycline and azithromycin therapy effective in treating severe scrub typhus
  • Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options